Aldosterone-mediated renal sodium transport requires intact mineralocorticoid receptor DNA binding in the mouse

Endocrinology (United States)

Volumn 156, Issue 8, 2015, Pages 2958-2968

  Cole, Timothy J ^a   Terella, Luke ^a   Morgan, James ^a   Alexiadis, Maria ^a   Yao, Yi Zhou ^a   Enriori, Pablo ^a   Young, Morag J ^a   Fuller, Peter J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; COMPLEMENTARY DNA; CORTICOSTERONE; CYSTEINE; EPITHELIAL SODIUM CHANNEL; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; RECOMBINASE; SERINE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CHLORIDE; THYMINE; DNA; PROTEIN BINDING; SODIUM; ZINC FINGER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CODON; CONTROLLED STUDY; DNA BINDING; ENZYME MECHANISM; FAILURE TO THRIVE; FATALITY; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENOME ANALYSIS; HORMONE RESPONSIVE ELEMENT; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE ABSORPTION; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SODIUM TRANSPORT; SODIUM URINE LEVEL; WEIGHT REDUCTION; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; ION TRANSPORT; KIDNEY; METABOLISM; MISSENSE MUTATION; PROTEIN DOMAIN; TRANSGENIC MOUSE;

ALDOSTERONE; AMINO ACID SEQUENCE; ANIMALS; DNA; GENE EXPRESSION REGULATION; GENE KNOCK-IN TECHNIQUES; ION TRANSPORT; KIDNEY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION, MISSENSE; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RECEPTORS, MINERALOCORTICOID; SODIUM; ZINC FINGERS;

EID: 84938702944     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1008     Document Type: Article

References (61)

1. Fuller PJ, Young MJ. Mechanisms of mineralocorticoid action. Hypertension. 2005;46:1227-1235.
2. Berger S, Bleich M, Schmid W, et al. Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism. Proc Natl Acad Sci USA. 1998;95:9424-9429.
3. Zennaro MC, Hubert EL, Fernandes-Rosa FL. Aldosterone resistance: structural and functional considerations and new perspectives. Mol Cell Endocrinol. 2012;350:206-215.
4. Odermatt A, Kratschmar DV. Tissue-specific modulation of mineralocorticoid receptor function by 11γ-hydroxysteroid dehydrogenases: an overview. Mol Cell Endocrinol. 2012;350:168-186.
5. De Kloet E, Vreugdenhil E, Oitzl MS, Jo?ls M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998;19:269-301.
6. Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ. Deletion of mineralocorticoid receptors from macrophages protects against DOC/salt-induced cardiac fibrosis and increased blood pressure. Hypertension. 2009;54:537-543.
7. Rickard AJ, Morgan J, Bienvenu LA, et al. Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/salt-mediated inflammation and cardiac fibrosis. Hypertension. 2012;60: 1443-1450.
8. Marzolla V, Armani A, Zennaro M-C, et al. The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol Cell Endocrinol. 2012;350:281-288.
9. Iqbal J, Andrew R, Cruden NL, et al. Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist. J Clin Endocrinol Metab. 2014;99:915-922.
10. McEwan IJ, Lavery D, Fischer K, Watt K. Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors. Nuc Rec Signal. 2007;5:1-6.
11. Pippal JB, Yao Y, Rogerson FM, Fuller PJ. Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor. Mol Endocrinol. 2009;23:1360-1370.
12. Hudson WH, Youn C, Ortlund EA. Crystal structure of the mineralocorticoid receptor DNA binding domain in complex with DNA. PLoS One. 2014;9(9):e107000.
13. Fagart J, Huyet J, Pinon GM, Rochel M, Mayer C, Rafestin-Oblin ME. Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat Struct Mol Biol. 2005;12:554-555.
14. Bledsoe RK, Madauss KP, Holt JA, et al. A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J Biol Chem. 2005;280:31283-31293.
15. Li Y, Suino K, Daugherty J, Xu HE. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol Cell. 2005;19:367-380.
16. Rogerson FM, Yao Y-Z, Elsass RE, Dimopoulos N, Smith BJ, Fuller PJ. A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors. Mol Endocrinol. 2007;21:817-828.
17. Gronemeyer H, Gustafsson J?, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nature Rev Drug Discov. 2004; 3:950-964.
18. Glass CK, Rosenfeld MG. The coregulator exchange in transcriptional functions of nuclear receptors. GenesDev. 2000;14:121-141.
19. Rogerson FM, Yao YZ, Young MJ, Fuller PJ. Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator. FASEB J. 2014;28:4200-4210.
20. Pearce D, Yamamoto KR. Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science. 1993;259:1161-1165.
21. De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-βB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev. 2003;24:488-522.
22. Lopez FJ, Ardecky RJ, Bebo B, et al. LGD-5552 an anti-inflammatory glucocorticoid ligand with reduced side effects, in vivo. Endocrinology. 2008;149:2080-2089.
23. Kolla V, Litwack G. Inhibition of mineralocorticoid-mediated transcription by NFβB. Arch Biochem Biophys. 2000;383:38-45.
24. Liden J, Delaunay F, Rafter I, Gustafsson J, Okret S. A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of ReIA transactivation. J Biol Chem. 1997;22:21467-21472.
25. Wissink S, Meijer O, Pearce D, van der Burg B, van der Saag PT. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J Biol Chem 2000. 2000;275:1321-1326.
26. Leroy V, de Seigneux S, Agassiz V. Aldosterone activates NF-βB in the collecting duct. J Am Soc Nephrol. 2009;20:131-144.
27. Terada Y, Ueda S, Hamada K, et al. Aldosterone stimulates nuclear factor-βB activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum- and glucocorticoid-inducible protein kinase-1. Clin Exp Nephrol. 2012;16:81-88.
28. Chantong B, Kratschmar DV, Nashev LG, Balazs Z, Odermatt A. Mineralocorticoid and glucocorticoid receptors differentially regulate NF-βB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells. J Neuroinflammation. 2012;9:260.
29. Caldenhoven E, Liden J, Wissink S, et al. Negative cross-talk between ReIA and the glucocorticoid receptor-a possible mechanism for the anti-inflammatory action of glucocorticoids. Mol Endocrinol. 1995;9:401-412.
30. CaprioM,NewfellBG,la Sala A, et al. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion. Circ Res. 2008;102:1359-1367.
31. Meijer OC, Williamson A, Dallman MF, Pearce D. Transcriptional repression of the 5-HT1A receptor promoter by corticosterone via mineralocorticoid receptors depends on the cellular context. J Neuroendocrinol. 2000;12:245-254.
32. Miner JN, Chang W, Chapman MS, et al. An orally active selective androgen receptor modulator is efficacious on bone, muscle and sex function with reduced impact on prostate. Endocrinology. 2007; 148:363-373.
33. Pedram A, Razandi M, Korach KS, Narayanan R, Dalton JT, Levin ER. ERγ selective agonist inhibits angiotensin-induced cardiovascular pathology in female mice. Endocrinology. 2013;154:4352-4364.
34. Dooley R, Harvey BJ, Thomas W. Non-genomic actions of aldosterone: from receptors and signals to membrane targets. Mol Cell Endocrinol. 2012;350:223-234.
35. Grossmann C, Gekle M. Interaction between mineralocorticoid receptor and epidermal growth factor receptor signaling. Mol Cell Endocrinol. 2012;350:235-241.
36. Reichardt HM, Kaestner KH, Tuckermann J, et al. The DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 1998;93:531-541.
37. Jakacka M, Ito M, Martinson F, Ishikawa T, Lee EJ, Jameson JL. An estrogen receptor (ERγ) deoxyribonucleic acid-binding domain knock-in mutation provides evidence for nonclassical ER pathway signaling in vivo. Mol Endocrinol. 2002;16:2188-2201.
38. Gast A, Neuschmid-Kaspar F, Klocker H, Cato AC. A single aminoacid exchange abolishes dimerization of the androgen receptor and causes Reifenstein syndrome. Mol Cell Endocrinol. 1995;111:93-98.
39. Cato ACB, Fuller PJ. What is in a name? Mol Cell Endocrinol. 2012;350:145.
40. Pearce D, N?ray-Fejes-T?th A, Fejes-T?th G. Determinants of subnuclear organization of mineralocorticoid receptor characterized through analysis of wild type and mutant receptors. J Biol Chem. 2001;277:1451-1456.
41. Takeuchi T,NomuraT, TsujitaM,et al. Flp recombinase transgenic mice of C57BL/6 strain for conditional gene targeting. Biochem Biophys Res Commun. 2002;293:953-957.
42. Rickard AJ, Morgan J, Chrissobolis S, Miller AA, Sobey CG, Young MJ. Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure. Hypertension. 2014;63:1033-1040.
43. PfafflMW.Anew mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
44. Chen W, Wilson JL, Khaksari M, Cowley MA, Enriori PJ. Abdominal fat analyzed by DEXA scan reflects visceral body fat and improves the phenotype description and the assessment of metabolic risk in mice. Am J Physiol. 2012;303:E635-E643.
45. Bleich M, Warth R, Schmidt-Hieber M, et al. Rescue of the mineralocorticoid receptor knock-out mouse. Eur J Physiol. 1999;438: 245-254.
46. Ziera T, Irlbacher H Fromm A, et al. Cnksr3 is a direct mineralocorticoid receptor target gene and plays a key role in the regulation of the epithelial sodium channel. FASEB J. 2009;23: 3936-3946.
47. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 1991;352:497-505.
48. McCurley A, Pires PW, Bender SB, et al. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med. 2012;18:1429-1433.
49. Galmiche G, Pizard A, Gueret A, et al. Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness. Hypertension. 2014;63:520-526.
50. Zhang X, Zhou Q, Chen L, et al. Mineralocorticoid receptor antagonizes Dot1a-Af9 complex to increase γENaC transcription. Am J Physiol. 2013;305:F1436-F1444.
51. Attali B, Latter H, Rachamin N, Garty H. A corticosteroid-induced gene expressing an "IsK-like" K- channel activity in Xenopus oocytes. Proc Natl Acad Sci USA. 1995;92:6092-6096.
52. Brennan FE, Fuller PJ. Acute regulation by corticosteroids of channel-inducing factor gene messenger ribonucleic acid in the distal colon. Endocrinology. 1999;140:1213-1218.
53. Sweadner KJ, Rael E. The FXYD gene family of small ion transport regulators or channels:cDNAsequence, protein signature sequence, and expression. Genomics. 2000;68:41-56.
54. Beguin P, Crambert G, Guennoun S, Garty H, Horisberger JD, Geering K. CHIF, a member of the FXYD protein family, is a regulator of Na.K-ATPase distinct from the -subunit. EMBO J. 2001;20: 3993-4002.
55. Brennan FE, Fuller PJ. Transcriptional control by corticosteroids of CHIF gene expression in the rat distal colon. Clin Exp Pharmacol Physiol. 1999;26:489-491.
56. Goldschmidt I, Grahammer F, Warth R, et al. Kidney and colon electrolyte transport in CHIF knockout mice. Cell Physiol Biochem. 2004;14:113-120.
57. Wald H, Goldstein O, Asher C, Yagil Y, Garty H. Aldosterone induction and epithelial distribution of CHIF. Am J Physiol. 1996; 271:F322-F329.
58. Jewell CM, Scoltock AB, Hamel BL, Yudt MR, Cidlowski JA. Complex human glucocorticoid receptor dim mutations define glucocorticoid induced apoptotic resistance in bone cells. Mol Endocrinol. 2012;26:244-256.
59. Schiller BJ, Chodankar R, Watson LC, Stallcup MR, Yamamoto KR. Glucocorticoid receptor binds half sites as a monomer and regulates specific target genes. Genome Biol. 2014;15:418.
60. Ahlbury-Dieker DL, Stride BD, Leder G, et al. DNA binding by estrogen receptor-γ is essential for the transcriptional response to estrogen in the liver and the uterus.MolEndocrinol. 2009;23:1544-1555.
61. Hewitt SC, Li L, Grimm SA, et al. NovelDNAmotif binding activity observed in vivo with an estrogen receptor γ mutant mouse. Mol Endocrinol. 2014;28:899-911.